Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates

(1) Background: The present study aimed to analyze medication adherence and its effect on blood pressure (BP) control and assess the prevalence of treatment-resistant hypertension (TRH) among newly treated hypertensive patients in the United Arab Emirates (UAE); (2) Methods: A retrospective chart re...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Akshaya Srikanth Bhagavathula, Syed Mahboob Shah, Elhadi Husein Aburawi
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	blood pressure hypertension medication adherence treatment-resistant hypertension control United Arab Emirates Medicine R
Acceso en línea:	https://doaj.org/article/69703f2419aa452daac132e3bc38fd45
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:69703f2419aa452daac132e3bc38fd45
record_format	dspace
spelling	oai:doaj.org-article:69703f2419aa452daac132e3bc38fd452021-11-11T17:39:30ZMedication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates10.3390/jcm102150362077-0383https://doaj.org/article/69703f2419aa452daac132e3bc38fd452021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5036https://doaj.org/toc/2077-0383(1) Background: The present study aimed to analyze medication adherence and its effect on blood pressure (BP) control and assess the prevalence of treatment-resistant hypertension (TRH) among newly treated hypertensive patients in the United Arab Emirates (UAE); (2) Methods: A retrospective chart review was conducted to evaluate 5308 naïve hypertensive adults registered for the treatment across Abu Dhabi Health Services (SEHA) clinics in Abu Dhabi in 2017. After collecting data regarding basic details and BP measurements, patients were followed up for six months. Patients who did not reach BP targets despite taking three or more antihypertensive medications were defined as TRH; (3) Results: The overall adherence to antihypertensive treatment was 42%. At 6-month, a significant reduction in BP was observed in patients adherent to medications (systolic: −4.5 mm Hg and diastolic: −5.9 mm Hg) than those who were nonadherent to antihypertensive therapy (1.15 mm Hg and 3.59 mm Hg). Among 189 patients using three or more antihypertensive medications for six months, only 34% (<i>n</i> = 64) were adherent to the treatment, and only 13.7% (<i>n</i> = 26) reached the BP target. The prevalence of TRH was 20.1%; (4) Conclusions: Medication adherence and BP control among the participants were suboptimal. The study shows a high prevalence of TRH among newly treated hypertensives in the UAE. More extraordinary efforts toward improving adherence to antihypertensive therapy and more focus toward BP control and TRH are urgently needed.Akshaya Srikanth BhagavathulaSyed Mahboob ShahElhadi Husein AburawiMDPI AGarticleblood pressurehypertensionmedication adherencetreatment-resistant hypertensioncontrolUnited Arab EmiratesMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5036, p 5036 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	blood pressure hypertension medication adherence treatment-resistant hypertension control United Arab Emirates Medicine R
spellingShingle	blood pressure hypertension medication adherence treatment-resistant hypertension control United Arab Emirates Medicine R Akshaya Srikanth Bhagavathula Syed Mahboob Shah Elhadi Husein Aburawi Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
description	(1) Background: The present study aimed to analyze medication adherence and its effect on blood pressure (BP) control and assess the prevalence of treatment-resistant hypertension (TRH) among newly treated hypertensive patients in the United Arab Emirates (UAE); (2) Methods: A retrospective chart review was conducted to evaluate 5308 naïve hypertensive adults registered for the treatment across Abu Dhabi Health Services (SEHA) clinics in Abu Dhabi in 2017. After collecting data regarding basic details and BP measurements, patients were followed up for six months. Patients who did not reach BP targets despite taking three or more antihypertensive medications were defined as TRH; (3) Results: The overall adherence to antihypertensive treatment was 42%. At 6-month, a significant reduction in BP was observed in patients adherent to medications (systolic: −4.5 mm Hg and diastolic: −5.9 mm Hg) than those who were nonadherent to antihypertensive therapy (1.15 mm Hg and 3.59 mm Hg). Among 189 patients using three or more antihypertensive medications for six months, only 34% (<i>n</i> = 64) were adherent to the treatment, and only 13.7% (<i>n</i> = 26) reached the BP target. The prevalence of TRH was 20.1%; (4) Conclusions: Medication adherence and BP control among the participants were suboptimal. The study shows a high prevalence of TRH among newly treated hypertensives in the UAE. More extraordinary efforts toward improving adherence to antihypertensive therapy and more focus toward BP control and TRH are urgently needed.
format	article
author	Akshaya Srikanth Bhagavathula Syed Mahboob Shah Elhadi Husein Aburawi
author_facet	Akshaya Srikanth Bhagavathula Syed Mahboob Shah Elhadi Husein Aburawi
author_sort	Akshaya Srikanth Bhagavathula
title	Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
title_short	Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
title_full	Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
title_fullStr	Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
title_full_unstemmed	Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates
title_sort	medication adherence and treatment-resistant hypertension in newly treated hypertensive patients in the united arab emirates
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/69703f2419aa452daac132e3bc38fd45
work_keys_str_mv	AT akshayasrikanthbhagavathula medicationadherenceandtreatmentresistanthypertensioninnewlytreatedhypertensivepatientsintheunitedarabemirates AT syedmahboobshah medicationadherenceandtreatmentresistanthypertensioninnewlytreatedhypertensivepatientsintheunitedarabemirates AT elhadihuseinaburawi medicationadherenceandtreatmentresistanthypertensioninnewlytreatedhypertensivepatientsintheunitedarabemirates
_version_	1718432004540727296

Medication Adherence and Treatment-Resistant Hypertension in Newly Treated Hypertensive Patients in the United Arab Emirates

Ejemplares similares